Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants.
Combined
Diphtheria-tetanus-acellular pertussis-inactivate
Infant
Vaccines
Journal
Clinical and experimental pediatrics
ISSN: 2713-4148
Titre abrégé: Clin Exp Pediatr
Pays: Korea (South)
ID NLM: 101761234
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
21
04
2021
accepted:
14
05
2021
pubmed:
9
6
2021
medline:
9
6
2021
entrez:
8
6
2021
Statut:
ppublish
Résumé
In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTaP-IPV-Hib-HepB (Hexaxim, Sanofi Pasteur), for use as a 3-dose primary series in infants aged 2, 4, and 6 months. The DTaP-IPV-Hib-HepB vaccine is highly immunogenic and safe and provides a long-term immune response based on studies performed in a variety of settings in many countries, including Korea. This report summarizes the Committee on Infectious Diseases of the Korean Pediatric Society guidelines for the use of this newly introduced hexavalent combination vaccine.
Identifiants
pubmed: 34098627
pii: cep.2021.00507
doi: 10.3345/cep.2021.00507
pmc: PMC8650817
doi:
Types de publication
Journal Article
Langues
eng
Pagination
602-607Références
J Korean Med Sci. 2016 Sep;31(9):1383-91
pubmed: 27510380
Vaccine. 2012 Oct 5;30(45):6492-500
pubmed: 22863658
Hum Vaccin Immunother. 2018 May 4;14(5):1257-1265
pubmed: 29333947
Lancet Infect Dis. 2010 Nov;10(11):738-9
pubmed: 21029981
Turk J Med Sci. ;47(4):1247-1256
pubmed: 29156870
Vaccine. 2018 Aug 28;36(36):5485-5494
pubmed: 28676382
Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S312-8
pubmed: 11709765
Ital J Pediatr. 2019 Nov 19;45(1):145
pubmed: 31744514
Epidemiol Infect. 2010 Nov;138(11):1621-9
pubmed: 20233496
Vaccine. 2017 Jul 13;35(32):4022-4028
pubmed: 28629923
Paediatr Drugs. 2019 Oct;21(5):397-408
pubmed: 31444785
MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):136-139
pubmed: 32027629
Pediatr Infect Dis J. 2017 Feb;36(2):209-215
pubmed: 27846055
J Glob Infect Dis. 2011 Jan;3(1):63-72
pubmed: 21572611
Pediatr Infect Dis J. 2017 Nov;36(11):e272-e282
pubmed: 28719500
Vaccine. 1990 Mar;8 Suppl:S56-9; discussion S60-2
pubmed: 2139286
Am J Manag Care. 2003 Jan;9(1 Suppl):S6-12
pubmed: 12564784
Expert Rev Vaccines. 2011 Jul;10(7):981-1005
pubmed: 21749196
Expert Opin Biol Ther. 2013 Apr;13(4):575-93
pubmed: 23441818
Vaccine. 2000 Nov 22;19(7-8):943-9
pubmed: 11115720
J Pediatr Health Care. 2003 Mar-Apr;17(2):53-7
pubmed: 12665726
Vaccine. 2011 Feb 11;29(8):1551-7
pubmed: 21215828
Vaccine. 2009 Oct 19;27(44):6110-5
pubmed: 19716459
Expert Rev Vaccines. 2021 Mar;20(3):319-330
pubmed: 33660582